Treatment and Managed Care Issues of Atopic Dermatitis

被引:0
作者
Ezzo, Danielle [1 ]
机构
[1] St Johns Univ, Dept Clin Hlth Profess, Coll Pharm & Hlth Sci, Jamaica, NY 11439 USA
关键词
TOPICAL CALCINEURIN INHIBITORS; QUALITY-OF-LIFE; TACROLIMUS OINTMENT; MAINTENANCE TREATMENT; COST-EFFECTIVENESS; DISEASE SEVERITY; CONTROLLED-TRIAL; OPEN-LABEL; CHILDREN; ECZEMA;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The specific cause of atopic dermatitis (AD) is not known. It is a multifactorial disease involving environmental agents, immune dysregulation, genetic predisposition, and defects in skin barrier function. Patients are typically classified as having mild, moderate, or severe disease. Most patients with AD can control their symptoms with various combinations of moisturizers, conventional prescription therapies, and lifestyle modifications, while patients with more severe disease may require adjunctive treatment with phototherapy, biologic treatments, or systemic immunosuppressants. As a result, patient-centered treatment plans are critical to patient care. The appropriate use of nonpharmacologic and pharmacologic treatment interventions combined with patient-specific written action plans could improve both patient health and medication outcomes.
引用
收藏
页码:S124 / S131
页数:8
相关论文
共 60 条
[1]  
[Anonymous], 2017, DUP PACK INS
[2]  
[Anonymous], WILL I KNOW WHAT DO
[3]  
[Anonymous], 2014, EL PACK INS
[4]  
[Anonymous], 2016, EUCR PACK INS
[5]  
[Anonymous], 2012, PROT PACK INS
[6]   Management of Difficult-to-Treat Atopic Dermatitis [J].
Arkwright, Peter D. ;
Motala, Cassim ;
Subramanian, Hamsa ;
Spergel, Jonathan ;
Schneider, Lynda C. ;
Wollenberg, Andreas .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2013, 1 (02) :142-151
[7]   Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency [J].
Aubert-Wastiaux, H. ;
Moret, L. ;
Le Rhun, A. ;
Fontenoy, A. M. ;
Nguyen, J. M. ;
Leux, C. ;
Misery, L. ;
Young, P. ;
Chastaing, M. ;
Danou, N. ;
Lombrail, P. ;
Boralevi, F. ;
Lacour, J. P. ;
Mazereeuw-Hautier, J. ;
Stalder, J. -F. ;
Barbarot, S. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (04) :808-814
[8]   Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis [J].
Beck, Lisa A. ;
Thaci, Diamant ;
Hamilton, Jennifer D. ;
Graham, Neil M. ;
Bieber, Thomas ;
Rocklin, Ross ;
Ming, Jeffrey E. ;
Ren, Haobo ;
Kao, Richard ;
Simpson, Eric ;
Ardeleanu, Marius ;
Weinstein, Steven P. ;
Pirozzi, Gianluca ;
Guttman-Yassky, Emma ;
Suarez-Farinas, Mayte ;
Hager, Melissa D. ;
Stahl, Neil ;
Yancopoulos, George D. ;
Radin, Allen R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02) :130-139
[9]   Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial [J].
Berth-Jones, J ;
Takwale, A ;
Tan, E ;
Barclay, G ;
Agarwal, S ;
Ahmed, I ;
Hotchkiss, K ;
Graham-Brown, RAC .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) :324-330
[10]   Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: A randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle [J].
Breneman, Debra ;
Fleischer, Alan B., Jr. ;
Abramovits, William ;
Zeichner, Joshua ;
Gold, Michael H. ;
Kirsner, Robert S. ;
Shull, Toni E. ;
Crowe, Andrew W. ;
Jaracz, Eileen ;
Hanifin, Jon M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (06) :990-999